✦ LIBER ✦

PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in Norway

✍ Scribed by T.R. Einarson; C. Vicente; R. Zilbershtein; C. Piwko

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacoeconomic analysis of paliperidon

✍ Thomas R. Einarson; Colin Vicente; Roman Zilbershtein; Charles Piwko; Christel N 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 Dutch ⚖ 656 KB

PMH23 A Cost-Effectiveness Analysis of t

✍ T.R. Einarson; H. Pudas; R. Zilbershtein; R. Jensen; A.T. Nielsen; C. Piwko; M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMH33 Cost Effectiveness of Paliperidone

✍ E. Walter; A. Dragosits; M. Said 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PMH30 Cost-Minimization-Analysis of Pali

✍ A. Dragosits; M. Said; E. Walter 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PMH35 COST-EFFECTIVENESS OF ORALLY DISSO

✍ H Ascher-Svanum; NM Furiak; RW Klein; LJ Smolen; PR Watson; AH Lawson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMH48 VALIDATING A COST-EFFECTIVENESS AN

✍ C Graham; J Mauskopf; AH Lawson; H Ascher-Svanum; D Bruhn; PR Watson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB